1st Quarter - Report
ROCK & ASSOCIATES for PRECISION PHARMACY
Firm
Client
Income
$11,250
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Issues related to Appropriations and report language funding the FDA, specifically as it relates to animal drug compounding. No bill numbers yet.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Health Issues HCR
Issues related to the NASEM report to the FDA on compounded bioidentical hormones, and issues related to GFI #256 on animal drug compounding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Pharmacy PHA
Issues related to animal drug compounding. No specific legislation yet.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.